Prostate Cancer
Concurrent targeting of HDAC and PI3K to overcome phenotypic heterogeneity of castration-resistant and neuroendocrine prostate cancers.
October 16, 2023
Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews.
October 16, 2023
177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior 223Ra (RALU Study).
October 16, 2023
Case-Matched Outcomes of Proton Beam and Intensity-Modulated Radiation Therapy for Localized Prostate Cancer.
October 13, 2023
Double trouble for prostate cancer: synergistic action of AR blockade and PARPi in non-HRR mutated patients.
October 12, 2023
MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer.
October 12, 2023
Chronic Glucocorticoid Use and Risk for Advanced Prostate Cancer at Presentation: A SEER-Medicare Cohort Study.
October 12, 2023